<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04111653</url>
  </required_header>
  <id_info>
    <org_study_id>2019-A01614-53</org_study_id>
    <nct_id>NCT04111653</nct_id>
  </id_info>
  <brief_title>Exploration of the Transfer of Barium From Thermal Mud</brief_title>
  <acronym>T2BT</acronym>
  <official_title>Exploration of the Transfer of Barium From Thermal Mud (T2BT Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Association Francaise pour la Recherche Thermale</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Association Francaise pour la Recherche Thermale</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      It involves conducting a clinical study on a population of healthy volunteers (age between 18
      and 30 years) without direct benefit for the subject to explore a transfer of barium in the
      blood and urine following applications of thermal mud. The main objective is to highlight an
      increase in serum barium level of at least twice.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The presence of barium in thermal clays was noted by the ARS (french administration) who
      interviewed the Directorate General of Health (DGS); the latter seized the National Academy
      of Medicine (June 2016) which reported in February 2017.

      In this report it was stated that there was no argument in favor of toxic phenomena related
      to the presence of barium but that it was appropriate, in particular, to evaluate a possible
      passage of barium in the skin in subjects who are treated with thermal mud

        -  by observing, where appropriate, an increase in serum and urinary barium levels in the
           subjects concerned and

        -  by measuring a possible depletion of barium in the sludge used. The DGS validated the
           various recommendations of the Academy and asked, in January 2018, the National Council
           of Thermal Establishments (CNETH) to implement the recommendations of the Academy.

      It will therefore be a prospective before-after interventional study, implementing 15 daily
      applications of 6 mud poultices made with a clay used as thermal clay and containing
      appreciable barium levels.

      A surveillance will be put in place with the event of suspected event, the volunteer can then
      be seen by a doctor.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 13, 2020</start_date>
  <completion_date type="Anticipated">September 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">July 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Measurement of the plasma level of barium</measure>
    <time_frame>3 weeks</time_frame>
    <description>Plasma level of barium</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Measurement of the urinary rate of barium</measure>
    <time_frame>3 weeks</time_frame>
    <description>Urinary rate of barium</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasma level of barium exceeds the level deemed tolerable by INRS (French Institute for Research and Security)</measure>
    <time_frame>3 weeks</time_frame>
    <description>plasma levels of barium</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients who doubles the urinary and plasma level of barium</measure>
    <time_frame>3 weeks</time_frame>
    <description>plasma and urinary levels of barium</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">36</enrollment>
  <condition>Mud Therapy</condition>
  <arm_group>
    <arm_group_label>Single arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Healthy volunteers</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Mud therapy</intervention_name>
    <description>Application of sludge poultice</description>
    <arm_group_label>Single arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  volunteers, healthy (without known and / or treated disease)

          -  18 to 30 years old,

          -  men and women, who can give their informed consent, presenting the elements of
             cutaneous and general tolerance of sludge applications

          -  patient affiliated to a social security scheme

        Exclusion Criteria:

          -  subject who can not give informed consent

          -  pregnant woman ; woman of childbearing years not wishing to have contraception
             available for the duration of the trial

          -  subject to a legal protection measure or a judicial review, subject having a known
             allergy to a heavy metal, a BMI greater than 30

          -  a characterized contact eczema, an active dermatosis, an acute affection, a disorder
             of the cutaneous sensitivity, an intolerance to the heat

          -  heart, kidney or lung disease that may be decompensated with the use of hot products

          -  a progressive disease (inflammatory, infectious or tumoral) potentially liable to
             worsen with the application of thermal physical agents
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Frédéric Bauduer, Pr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institut du thermalisme</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jerome Dimet, PhD</last_name>
    <phone>5.58.05.29.30</phone>
    <phone_ext>33</phone_ext>
    <email>jerome.dimet@ght40.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Anne-Hélène Boivin</last_name>
    <phone>5.58.05.29.09</phone>
    <phone_ext>33</phone_ext>
    <email>anne-helene.boivin@ght40.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Institut du Thermalisme</name>
      <address>
        <city>Dax</city>
        <zip>40100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karine Dubourg, PhD</last_name>
      <phone>05.58.56.89.94</phone>
      <email>karine.dubourg@u-bordeaux.fr</email>
    </contact>
    <investigator>
      <last_name>Frédéric Bauduer, Pr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Roques CF, Trèves R, Queneau P, Bontoux D. Avis de l'académie nationale de médecine relatif à l'évaluation des risques sanitaires liés à la présence de baryum dans des argiles constitutives des boues thermales et à l'absence de contrôle sanitaire des boues thermales. Bull Acad Ntle Méd., , 201: 13-38, 2017.</citation>
  </reference>
  <reference>
    <citation>Ainouche R, Tabone W, Bouvier CE, Renaud V. Usage thérapeutique (des boues thermales), panorama du thermalisme français en 2013. Bulletin de l'AFTH (Association Française des Techniques Hydrothermales), 2014, n° 25, Symposium Utilisation des boues en établissement thermal, Enghien les Bains, Novembre 2013, pp. 7-11</citation>
  </reference>
  <reference>
    <citation>Gomes C, Carretero MI, Pozo M, Maraver F, Cantista P et al. Peloids and pelotherapy : historical evolution, classification and glossary. Applied clay science 75-76:28-38, 2013.</citation>
  </reference>
  <reference>
    <citation>Liu H, Zeng C, Gao SG, Yang T, Luo W, Li YS, Xiong YL, Sun JP, Lei GH. The effect of mud therapy on pain relief in patients with knee osteoarthritis: a meta-analysis of randomized controlled trials. J Int Med Res. 2013 Oct;41(5):1418-25. doi: 10.1177/0300060513488509. Epub 2013 Sep 5.</citation>
    <PMID>24008567</PMID>
  </reference>
  <reference>
    <citation>Roques CF. Mud Therapy. Data of clinical evidence. Balnea 10:57-62, 2015.</citation>
  </reference>
  <reference>
    <citation>Xiang J, Wu D, Li J. Clinical Efficacy of Mudpack Therapy in Treating Knee Osteoarthritis: A Meta-Analysis of Randomized Controlled Studies. Am J Phys Med Rehabil. 2016 Feb;95(2):121-31. doi: 10.1097/PHM.0000000000000354.</citation>
    <PMID>26203645</PMID>
  </reference>
  <reference>
    <citation>Roques CF, Queneau P. [SPA therapy for pain of patients with chronic low back pain, knee osteo-arthritis and fibromyalgia]. Bull Acad Natl Med. 2016 Mar;200(3):575-86; discussion 586-7. Review. French.</citation>
    <PMID>28644605</PMID>
  </reference>
  <reference>
    <citation>World Health Organization (WHO) - 2001 - IPCS (International Programme on Chemical Safety) - Concise international chemical assessment document 33 - barium and barium compounds. 57 pp</citation>
  </reference>
  <reference>
    <citation>Conseil canadien des Ministres de l'environnement - Recommandations canadiennes pour la qualité des sols - environnement et santé humaine. Le baryum. Feuillet d'information 2013, 1 doc 11 pp</citation>
  </reference>
  <reference>
    <citation>Kravchenko J, Darrah TH, Miller RK, Lyerly HK, Vengosh A. A review of the health impacts of barium from natural and anthropogenic exposure. Environ Geochem Health. 2014 Aug;36(4):797-814. doi: 10.1007/s10653-014-9622-7. Epub 2014 May 21. Review.</citation>
    <PMID>24844320</PMID>
  </reference>
  <reference>
    <citation>INRS - base de données de fiches toxicologiques. Baryum et composés. Fiche toxicologique complète n°125. 1 doc 12 pp, 2012</citation>
  </reference>
  <reference>
    <citation>Ding C, Pan Y, Zhang A, Zhu C, Liu D, Xu G, Zheng Y, Yan H. [Distribution of rubidium, cesium, beryllium, strontium, and barium in blood and urine in general Chinese population]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2015 Dec;33(12):894-9. doi: 10.3760/cma.j.issn.1001-9391.2015.12.004. Chinese.</citation>
    <PMID>27122328</PMID>
  </reference>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>September 30, 2019</study_first_submitted>
  <study_first_submitted_qc>September 30, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 1, 2019</study_first_posted>
  <last_update_submitted>July 8, 2020</last_update_submitted>
  <last_update_submitted_qc>July 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>mud therapy</keyword>
  <keyword>natural mineral water</keyword>
  <keyword>barium</keyword>
  <keyword>poultices</keyword>
  <keyword>skin transfer</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

